Clinical reports note that patients often experience rapid improvements in headache, dizziness, weakness, and fatigue within minutes to an hour after IV rehydration
Gastrointestinal issues like nausea and vomiting were the most common
Injectable BPC-157 Wider Systemic Distribution Injectable BPC-157 bypasses the digestive system, allowing for greater systemic distribution in the body
In smaller studies, without a placebo control, liraglutide lowered levels of some additional markers of inflammation [sCD163 (246), selectin E, and plasminogen activator inhibitor-1 (PAI-1) (247)], while leaving others unchanged [VCAM-1, CRP, and CCL-2 (247)]
Henry Sobo
People with a resting heart rate already above 100 beats per minute, or with conditions like hypertrophic cardiomyopathy or unstable arrhythmias, need careful evaluation before considering retatrutide